DOI : 10.1055/s-00000020

Geburtshilfe und Frauenheilkunde

Issue 11 · Volume 78 · November 2018 DOI: 10.1055/s-008-41819

Kommission für Translationale Forschung der Arbeitsgemeinschaft für Gynäkologische Onkologie AGO e.V.
Abstracts of the 10th Scientific Symposium of the Comission for Translational Research of the Working group for Gynecologic Oncology AGO e.V.
Düsseldorf, 07.–08.09.2018

Sprecher AGO-TraFo: Peter A. Fasching
Abstracts (HTML) List of Authors
  • 01
    Stepputtis, SS; Metzger, E; Strietz, J; Stickeler, E; Schüle, R; Maurer, J:

    KDM 4 Inhibition Targets Breast Cancer Stem-like Cells

  • 04
    Dittmer, A; Dittmer, J:

    Long-term exposure to carcinoma-associated fibroblasts makes breast cancer cells addictive to integrin β1

  • 05
    Kommoss, S; Heitz, F; Winterhoff, BJN; Wang, C; Sehouli, J; Aliferis, C; Kimmig, R; Wang, J; Ma, S; de Gregorio, N; Mahner, S; du Bois, A; Tourani, R; Park-Simon, TW; Baumann, K; Taran, FA; Kommoss, F; Schroeder, W; Dowdy, SC; Pfisterer, J:

    Significant Overall Survival Improvement In Proliferative Subtype Ovarian Cancer Patients Receiving Bevacizumab

  • 06
    Banys-Paluchowski, M; Milde-Langosch, K; Fehm, T; Witzel, I; Oliveira-Ferrer, L; Schmalfeldt, B; Müller, V:

    Clinical relevance of H-RAS, K-RAS and N-RAS in a large cohort of primary breast cancer patients

  • 08
    Hedemann, N; Yousry Youssef Yanni, C; Rogmans, C; Tribian, N; Sebens, S; Wesch, D; Schmidt-Arras, D; Weimer, J; Arnold, N; Maass, N; Bauerschlag, DO:

    A Disintegrin and Metalloprotease 17 (ADAM17) and its downstream signaling in chemotherapeutic resistance of ovarian cancer

  • 09
    Feuerborn, J; Yousry Youssef Yanni, C; Rogmans, C; Treeck, L; Arnold, N; Maass, N; Bauerschlag, DO; Hedemann, N:

    Funktion des Nectin-4 bei der Entstehung von Resistenzmechanismen im Ovarialkarzinom und die Validierung als potenziell prädiktiver und prognostischer Marker

  • 10
    Müller, C; Juhasz-Böss, S; Schmidt, G; Gabriel, L; Hayo, C; Radosa, J; Solomayer, EF; Breitbach, GP; Juhasz-Böss, I:

    Einflussfaktoren auf den Beginn einer neoadjuvanten Chemotherapie bei Mammakarzinom

  • 11
    Ludescher, M; Stamm, N; Fehm, T; Neubauer, H:

    PGRMC1 interacts with proteins of the cholesterol synthesis pathway resulting in altered cholesterol metabolism in breast cancer cells

  • 15
    Honisch, E; Fröhlich, RL; Vesper, AS; Beyer, I; Rudelius, M; Köhrer, K; Scheuring, S; Fehm, T; Niederacher, D:

    Identifizierung von Mutationsprofilen hereditärer BRCA1-assoziierter TNBCs

  • 20
    Weimer, J; Nusilati, A; Tiemann, K; Stope, MB; Mustea, A; Karow, D; Hamann, S; Hedemann, N; Flörkemeier, I; Röcken, C; Bauerschlag, D; Arnold, N; Maass, N:

    Array based Copy number variations (aCNV) are able to differ classes in endometrial carcinoma

  • 21
    Nusilati, A; Weimer, J; Tiemann, K; Stope, MB; Mustea, A; Karow, D; Hamann, S; Hedemann, N; Flörkemeier, I; Röcken, C; Bauerschlag, D; Arnold, N; Maass, N:

    Imbalances and loss of heterozygosity (LOH) in endometrial carcinoma detected by array based Copy number variations (aCNV)

  • 22
    Esser, K; Kulik, A; Klinger, A; Fleischer, E; Neubauer, H; Niederacher, D; Fehm, T:

    Lead structure optimization of compounds identified to induce differentiation in solid tumors

  • 24
    Meier, S; Köster, F; Baum, S; Rody, A; Bräutigam, K:

    Analyse und Vergleich von HPV-Genotypen in unterschiedlichen Regionen des weiblichen Anogenitaltrakts und des Hals-Rachenraums

  • 25
    Banys-Paluchowski, M; Fehm, T; Witzel, I; Aktas, B; Fasching, PA; Hartkopf, A; Janni, W; Kasimir-Bauer, S; Pantel, K; Schön, G; Rack, B; Riethdorf, S; Solomayer, EF; Müller, V:

    The prognostic relevance of urokinase-type plasminogen activator (uPA) in the blood of patients with metastatic breast cancer

  • 27
    Kasoha, M; Takacs, Z; Radosa, J; Bohle, R; Schmidt, G; Linxweiler, M; Schick, B; Juhasz-Böss, I; Solomayer, EF:

    Protein expression of SEC62 in triple-negative breast cancer

  • 28
    Blum, S; Häberle, L; Tchartchian, G; Schippert, C; Fehm, T; Hartung, CP; Widschwendter, P; Reicke, S; Füger, T; Germeyer, A; Oppelt, P; Lange, J; Fleisch, M; Renner, SP; Hein, A; Fasching, PA; Beckmann, MW; Burghaus, S:

    Cancers in Patients with Endometriosis

  • 29
    Kasoha, M; Radosa, J; Solomayer, EF; Juhasz-Böss, I; Bohle, RM; Schmidt, G:

    Identifikation von Prognosefaktoren beim triple-negativen Mammakarzinom

  • 30
    Huebner, H; Erber, R; Hein, A; Lux, MP; Jud, S; Kremer, AN; Kranich, H; Mackensen, A; Häberle, L; Hack, C; Rauh, C; Wunderle, M; Gaß, P; Rabizadeh, S; Brandl, AL; Langemann, H; Volz, B; Nabieva, N; Schulz-Wendtland, R; Dudziak, D; Beckmann, MW; Hartmann, A; Fasching, PA; Rübner, M:

    TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients – First Results on the Influence of Tumor-Infiltrating Lymphocytes